Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease.

Item

http://www.wikidata.org/entity/Q36354376

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Effect of ranolazine on left v ...... with coronary artery disease.

@ast

Effect of ranolazine on left v ...... with coronary artery disease.

@en

type

Item

label

Effect of ranolazine on left v ...... with coronary artery disease.

@ast

Effect of ranolazine on left v ...... with coronary artery disease.

@en

prefLabel

Effect of ranolazine on left v ...... with coronary artery disease.

@ast

Effect of ranolazine on left v ...... with coronary artery disease.

@en

P1476

Effect of ranolazine on left v ...... s with coronary artery disease

@en

P2093

Ami E Iskandrian

http://www.w3.org/2001/XMLSchema#string

Ernest V Garcia

http://www.w3.org/2001/XMLSchema#string

Jaekyeong Heo

http://www.w3.org/2001/XMLSchema#string

Ji Chen

http://www.w3.org/2001/XMLSchema#string

Luiz Belardinelli

http://www.w3.org/2001/XMLSchema#string

Rajesh Venkataraman

http://www.w3.org/2001/XMLSchema#string

P2860

Heart failure with normal left ventricular ejection fraction

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.

Left-ventricular systolic and diastolic dyssynchrony as assessed by multi-harmonic phase analysis of gated SPECT myocardial perfusion imaging in patients with end-stage renal disease and normal LVEF

Left ventricular diastolic dyssynchrony assessed with phase analysis of gated myocardial perfusion SPECT: a comparison with tissue Doppler imaging.

Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine.

Late sodium current inhibition as a new cardioprotective approach.

Prevention of myocardial enzyme release by ranolazine in a primate model of ischaemia with reperfusion.

B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Corona

A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.

P304

1440-1445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2012.06.055

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Fadi G. Hage

P577

2012-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22884560

http://www.w3.org/2001/XMLSchema#string

P932

3483406

http://www.w3.org/2001/XMLSchema#string